In the Netherlands, approximately 1 out of 8 women is diagnosed with breast cancer. This diagnosis has a major impact on someoneís life. The treatment of breast cancer often involves chemotherapy, which has the potential side effect of changing the body composition. These changes in body composition may cause health risks, which is why the COBRA study focuses on this topic.
COBRA stands for Change Of Body composition in BReast cancer: All-in assessment. The research team investigates changes in adipose tissue and muscular tissue during chemotherapy. The study compares 300 women with breast cancer who are treated with or undergoing chemotherapy with 300 women who have not been diagnosed with breast cancer.
The COBRA study is conducted by Wageningen University and VU University Amsterdam in cooperation with several hospitals throughout the Netherlands. The study started in April 2013 and is financed by the Dutch Cancer Society (KWF Kankerbestrijding) and Alpe díHuZes.